Member Article

Durham pharma plc appoints acting CEO as search for Scaife successor continues

Durham-based pharmaceutical firm Quantum Pharma Plc has announced that Chris Rigg is the company’s new acting Chief Executive Officer.

Chris joined Quantum Pharma in November 2015 and was promoted the role of Chief Financial Officer in March.

Whilst the firm is in the process of recruiting a permanent figurehead, Mr Rigg takes over the reigns from outgoing CEO Andrew Scaife, who last month tendered his resignation as a Director of the firm for family reasons.

Chris has a wealth of relevant experience in growing and leading businesses across a number of sectors and industries and has held a number of senior positions, including most recently CEO of Northern Recruitment Group.

Other senior roles include Managing Director of eaga plc’s solar division and Head of Large Corporate Lending at Barclays in the North East.

Chris will combine the role with his duties as CFO. A search process for a new CEO has commenced and the Company will provide an update on this in due course.

John Clarke, Chairman of Quantum Pharma, commented: “The Board joins me in thanking Chris for accepting the position of Acting CEO whilst we continue our search for a permanent CEO.

“Chris has excellent knowledge of the group and its operations and is well placed to drive the business forward over the coming months.”